Entry Detail



General Information

Database ID:exR0755501
RNA Name:AFDN
RNA Type:mRNA
Chromosome:chr6
Starnd:+
Coordinate:
Start Site(bp):167826922End Site(bp):167972023
External Links:ENSG00000130396



Disease Information

Disease Name:Glioblastoma Multiforme
Disease Category:Cancers
MeSH ID:D005909
Type:Neoplasms/Neoplasms, Glandular and Epithelial
Alias:Glioblastoma//Glioblastomas//Astrocytoma, Grade IV//Astrocytomas, Grade IV//Grade IV Astrocytoma//Grade IV Astrocytomas//Glioblastoma Multiforme//Giant Cell Glioblastoma//Giant Cell Glioblastomas//Glioblastoma, Giant Cell//Glioblastomas, Giant Cell



Expression Detail

GEO ID:GSE106804
Description:Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles
Experimental Design:Cancer vs Control
Case Disease Type:Glioblastoma Multiforme
Case Disease SubType:NA
Case Sample:Glioblastoma Multiforme
Control Sample:Healthy
Number of Case:13
Number of Control:6
Number of Samples:19





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
WDR36
chr5
111091716
111130502
+
AGO3
chr1
35930718
36072500
+
TXNRD1
chr12
104215779
104350307
+
TOMM34
chr20
44942130
44960397
-
NFE2L1
chr17
48048329
48061545
+
DDX5
chr17
64498254
64508199
-
TMEM243
chr7
87196160
87220587
-
PABPC3
chr13
25095868
25099254
+
DHPS
chr19
12675717
12681880
-
CALU
chr7
128739292
128773400
+
NKTR
chr3
42600655
42648735
+
SON
chr21
33543038
33577481
+
MT-CO3
chrMT
9207
9990
+
UVSSA
chr4
1347208
1395989
+
MYB
chr6
135181308
135219173
+
HOXB7
chr17
48607232
48633572
-
ZNF395
chr8
28345590
28402701
-
SREBF2
chr22
41833079
41907307
+
KHSRP
chr19
6413348
6424794
-
RTEL1-TNFRSF6B
chr20
63659300
63698684
+
PANK3
chr5
168548495
168579368
-
FDFT1
chr8
11795573
11839304
+
TUBA1A
chr12
49184795
49189080
-
RINL
chr19
38867830
38878275
-
PPP1CA
chr11
67398183
67421183
-
SMC1A
chrX
53374149
53422728
-
ACTG1
chr17
81509971
81523847
-
NIPSNAP1
chr22
29554808
29581327
-
CYTH2
chr19
48469208
48482314
+
ARHGDIB
chr12
14942031
14961728
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-652-3p
chrX
110055389
110055409
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC011498.1
chr19
4457962
4471493
-
AC067930.4
chr8
143573490
143577397
+
AD000090.1
chr19
35557956
35581954
+
AL162586.1
chr9
127816066
127822520
+
AP005263.1
chr18
9102736
9254346
+
LINC00205
chr21
45288050
45297806
+
LINC01578
chr15
92819540
92899701
+
MALAT1
chr11
65497688
65506516
+
NEAT1
chr11
65422774
65445540
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:NA
Sample Source:NA
Source Fraction:NA
Platform:NA
Method:NA
Num of detected RNA Type:NA
Num of detected RNAs of this Type:NA
Sample treatment protocol:NA
RNA Extract protocol:NA
RNA library preparation protocol:NA



Reference

PMID:29330365
Title:Engineered nanointerfaces for microfluidic isolation and molecular profiling of tumor-specific extracellular vesicles.
Author:Re¨¢tegui E, van der Vos KE, Lai CP, Zeinali M, Atai NA, Aldikacti B, Floyd FP Jr, H Khankhel A, Thapar V, Hochberg FH, Sequist LV, Nahed BV, S Carter B, Toner M, Balaj L, T Ting D, Breakefield XO, Stott SL.
Journal:Nat Commun. 2018 Jan 12;9(1):175.
Description:Tumor-derived EVs have the potential to be utilized as disease-specific biomarkers, and genes specific to GBM as well as transcripts that are hallmarks for the four genetic subtypes of the disease.